ETPrime

Dolphin Medical Services Share Price

  • 2.20-0.11 (-4.76%)
  • Volume: 11,137
BSE
  • Closed
  • Last Updated On: 16 Jun, 2025, 03:30 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Dolphin Medical Services Share Price
  • 2.20-0.11 (-4.76%)
  • Volume: 11,137
Advertisment

Dolphin Medical share price insights

  • Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

  • Company has spent 1.22% of its operating revenues towards interest expenses and 8.47% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Dolphin Medical Services Ltd. share price moved down by -4.76% from its previous close of Rs 2.31. Dolphin Medical Services Ltd. stock last traded price is 2.20

    Share PriceValue
    Today/Current/Last-2.20
    Previous Day-2.31

InsightsDolphin Medical

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		-99.46
    EPS - TTM
    (₹)    		-0.02
    MCap
    (₹ Cr.)    		3.49
    Sectoral MCap Rank
    		54
    PB Ratio
    (x)    		0.33
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-0.65
    3 Months-0.39
    6 Months0.20
    1 Year0.08
    3 Years0.21

    		-0.65
    VWAP
    (₹)    		2.21
    52W H/L
    (₹)
    3.30 / 1.74

    Dolphin Medical Share Price Returns

    1 Day-4.76%
    1 WeekN.A.
    1 MonthN.A.
    3 MonthsN.A.
    1 YearN.A.
    3 Years31.74%
    5 Years89.66%

    ET Stock ScreenersTop Score Companies

    Check whether Dolphin Medical belongs to analysts' top-rated companies list?

    View Stock Screeners

    Dolphin Medical News & Analysis

    View all Dolphin Medical Share News & Announcements

    Dolphin Medical Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Dolphin Medical Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Dolphin Medical Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 1.22% of its operating revenues towards interest expenses and 8.47% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income0.150.250.260.150.15
      Total Income Growth (%)-39.45-3.5974.750.81-30.41
      Total Expenses0.220.240.240.140.27
      Total Expenses Growth (%)-10.741.3375.04-49.5230.54
      EBIT-0.060.010.020.01-0.12
      EBIT Growth (%)-797.83-57.8071.65--2,334.55
      Profit after Tax (PAT)-0.070.010.020.01-0.13
      PAT Growth (%)-1,114.49-64.4388.35-0.00
      EBIT Margin (%)-42.043.658.338.48-82.76
      Net Profit Margin (%)-45.842.747.426.88-89.49
      Basic EPS (₹)-0.050.010.010.01-0.09
      Annual FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
      Total Revenue0.720.380.961.143.77
      Total Revenue Growth (%)89.93-60.63-16.18-69.63-10.54
      Total Expenses0.790.971.823.095.21
      Total Expenses Growth (%)-18.87-46.75-41.11-40.7327.62
      Profit after Tax (PAT)-0.05-0.57-0.86-1.98-1.49
      PAT Growth (%)-----0.01
      Operating Profit Margin (%)-2.35-146.84-85.02-108.98-7.09
      Net Profit Margin (%)-8.16-152.48-90.22-173.28-39.61
      Basic EPS (₹)-0.03-0.38-0.57-1.31-0.99
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue0.820.720.650.566.02
      Total Revenue Growth (%)14.0910.3916.31-90.752,524.98
      Total Expenses0.850.810.770.736.32
      Total Expenses Growth (%)4.296.034.41-88.40964.48
      Profit after Tax (PAT)-0.03-0.10-0.12-0.19-0.31
      PAT Growth (%)-----
      Operating Profit Margin (%)-2.68-12.79-17.72-32.05-60.45
      Net Profit Margin (%)-4.33-15.33-20.38-36.03-65.99
      Basic EPS (₹)-0.02-0.07-0.08-0.12-0.21

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
      Total Assets21.6821.6722.3023.3024.69
      Total Assets Growth (%)0.04-2.84-4.26-5.66-3.39
      Total Liabilities8.848.798.858.998.42
      Total Liabilities Growth (%)0.61-0.72-1.546.748.00
      Total Equity12.8412.8813.4514.3116.27
      Total Equity Growth (%)-0.35-4.24-5.98-12.08-8.39
      Current Ratio (x)29.5915.9717.4017.3617.80
      Total Debt to Equity (x)0.640.630.610.580.47
      Contingent Liabilities-----
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets12.0812.1312.1712.2312.33
      Total Assets Growth (%)-0.41-0.33-0.49-0.81-31.04
      Total Liabilities2.042.062.001.931.84
      Total Liabilities Growth (%)-0.973.003.634.89-74.01
      Total Equity10.0410.0710.1810.3010.49
      Total Equity Growth (%)-0.30-1.08-1.17-1.81-2.87
      Current Ratio (x)3.432.962.992.932.98
      Total Debt to Equity (x)0.090.080.070.070.06
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
      Net Cash flow from Operating Activities-0.120.050.180.151.30
      Net Cash used in Investing Activities0.010.00-0.17-0.12-0.49
      Net Cash flow from Financing Activities0.11-0.05-0.02-0.03-0.88
      Net Cash Flow1,123.000.000.000.00-0.08
      Closing Cash & Cash Equivalent0.010.010.010.010.01
      Closing Cash & Cash Equivalent Growth (%)1.58-26.83-29.3920.09-87.19
      Total Debt/ CFO (x)-67.00175.9743.7953.865.92
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-0.06-0.05-0.07-0.100.27
      Net Cash used in Investing Activities0.00----
      Net Cash flow from Financing Activities0.060.050.070.07-0.25
      Net Cash Flow0.000.000.00-0.020.03
      Closing Cash & Cash Equivalent0.020.020.010.010.04
      Closing Cash & Cash Equivalent Growth (%)22.3219.9817.30-66.92253.13
      Total Debt/ CFO (x)-14.51-17.84-10.93-6.932.24

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Losing Shareholder's Money

        Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
      Annual FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
      Return on Equity (%)-0.36-4.48-6.46-13.88-9.18
      Return on Capital Employed (%)-0.06-2.56-3.67-5.36-1.08
      Return on Assets (%)-0.21-2.65-3.87-8.49-6.03
      Interest Coverage Ratio (x)-0.24-14.47-17.77-1.77-0.23
      Asset Turnover Ratio (x)2.611.734.294.8915.23
      Price to Earnings (x)-39.06-3.47-1.85-0.84-1.99
      Price to Book (x)0.140.160.120.120.18
      EV/EBITDA (x)31.01-277.52-96.45-16.6628.21
      EBITDA Margin (%)56.85-9.66-10.55-52.3210.07
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)-0.33-1.03-1.22-1.81-2.97
      Return on Capital Employed (%)-0.18-0.75-0.94-1.44-2.45
      Return on Assets (%)-0.27-0.85-1.02-1.53-2.53
      Interest Coverage Ratio (x)4.39-4.22-4.91-11.07-22.98
      Asset Turnover Ratio (x)0.060.060.050.040.03
      Price to Earnings (x)-102.04-39.37-19.16-16.05-7.24
      Price to Book (x)0.340.400.230.290.21
      EV/EBITDA (x)101.40-119.49-68.24-35.34-12.69
      EBITDA Margin (%)5.35-5.94-7.46-19.99-47.03

    Financial InsightsDolphin Medical

    • Income (P&L)
    • Ratios

      • Employee & Interest Expense

        Company has spent 1.22% of its operating revenues towards interest expenses and 8.47% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

      • Losing Shareholder's Money

        Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Dolphin Medical Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Dolphin Medical Peer Comparison

    Peers InsightsDolphin Medical

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Dolphin Medical Shareholding Pattern

      • Loading...
        Showing Dolphin Medical Shareholding as on Mar 2025
        CategoryMar 2025Dec 2024Sep 2024Jun 2024
        Promoters26.4426.4426.4426.44
        Pledge0.000.000.000.00
        FII0.000.000.000.00
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others73.5673.5673.5673.56
      • Showing Shareholding as on Mar 2025
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters39,92,30126.44 %0.00
        Pledge00.00 %0.00
        Others1,11,07,65173.56 %0.00

      Dolphin Medical MF Ownership

      MF Ownership details are not available.

      Top Searches:
      Dolphin Medical News Dolphin Medical Quarterly Results Dolphin Medical Dividend Dolphin Medical Q1 ResultsDolphin Medical Q2 ResultsDolphin Medical Q3 ResultsDolphin Medical Q4 Results

      Dolphin Medical Corporate Actions

      • Meeting DateAnnounced onPurposeDetails
        Apr 12, 2025Apr 04, 2025Board MeetingAudited Results
        Feb 10, 2025Jan 20, 2025Board MeetingQuarterly Results
        Nov 12, 2024Nov 05, 2024Board MeetingQuarterly Results
        Oct 30, 2024Oct 05, 2024AGMBook closure from Oct 24, 2024 to Oct 30, 2024
        Oct 05, 2024Oct 03, 2024Board MeetingA.G.M.

      • Dividend announcements are not available.

      • All TypesEx-DateRecord DateAnnounced onDetails
        RightsAug 29, 2005-May 30, 2005Rights ratio: 3 share for every 1 held at a price of Rs 12.0

      About Dolphin Medical

      Dolphin Medical Services Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 3.32 Crore) operating in Hospitals & Allied Services sector. Dolphin Medical Services Ltd. key Products/Revenue Segments include Diagnostics for the year ending 31-Mar-2024. Show More

      • Executives

      • Auditors

      • GV

        G V Mohan Prasad

        Managing Director & CEO
        ML

        M Lakshmi Sudha

        WholeTime Director & CFO
        DM

        Dwarakanath Madala

        Independent Director
        NS

        Narendra Seena Karkera

        Independent Director
        Show More
      • SMV & Co.
        Pinnamaneni & Co.

      Industry

      Hospital

      Key Indices Listed on

      -

      Address

      No.417, Sanali Heavens,Ameerpet,Hyderabad, Telangana - 500073

      Contact

      [email protected]

      www.dolphinmedicalservices.com

      More Details

      FAQs about Dolphin Medical share

      • 1. What's Dolphin Medical share price today and what are Dolphin Medical share returns ?
        Dolphin Medical share price is Rs 2.20 as on 16 Jun, 2025, 03:30 PM IST. Dolphin Medical share price is down by 4.76% based on previous share price of Rs. 2.31.
      • 2. What's the market capitalization of Dolphin Medical?
        Dolphin Medical share has a market capitalization of Rs 3.49 Cr. Within Hospitals & Allied Services sector, it's market cap rank is 54.
      • 3. What is Dolphin Medical's 52 week high / low?
        Dolphin Medical share price saw a 52 week high of Rs 3.30 and 52 week low of Rs 1.74.
      • 4. What is the PE & PB ratio of Dolphin Medical?
        The PE ratio of Dolphin Medical stands at -99.46, while the PB ratio is 0.33.
      • 5. What are the returns for Dolphin Medical share?
        Return Performance of Dolphin Medical Shares:
        • 1 Week: Dolphin Medical share price moved remain unchanged by N.A.
        • 6 Month: Dolphin Medical share price moved remain unchanged by N.A.

      Trending in Markets

      Top Gainers As on 03:59 PM | 20 Jun 2025

      GRSE3,287.60
      309.30 (10.39%)
      BEML4,639.50
      432.90 (10.29%)
      ABB Power18,684.00
      1650.00 (9.69%)
      Swiggy389.50
      33.40 (9.38%)
      MCX India8,085.00
      574.00 (7.64%)

      Top Losers As on 03:59 PM | 20 Jun 2025

      Tata Teleservices63.62
      -13.28 (-17.27%)
      Hindustan Zinc438.60
      -78.65 (-15.21%)
      AstraZeneca8,871.00
      -1324.00 (-12.99%)
      International Gemmol345.95
      -45.05 (-11.52%)
      Concord Biotech Ltd.1,837.30
      -226.30 (-10.97%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      Business News›Markets›Stocks›Stock Price Quotes›Dolphin Medical Share Price
      The Economic Times
      BrowseCompanies:
      OSZAR »